| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |